Tilda R 53 US 382889Recalls & reported problems
BIOTRONIK SE & Co. KG · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 04035479143305), received between Nov 6, 2019 and Apr 19, 2021 — classified as 2 injuries, 5 malfunctions.
The most frequently reported specific device problem is “Over-Sensing” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Over-Sensing3
- Adverse Event Without Identified Device or Use Problem2
- Fracture2
- Ambient Noise Problem1
- Low impedance1
- Naturally Worn1
Patient problems
- No Known Impact Or Consequence To Patient4
- Unspecified Infection2
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 19, 2021Over-Sensing; Over-Sensing
REPORTEDLY, THE PATIENT HAD A HISTORY OF MINOR ATRIAL OVERSENSING THAT WAS PREVIOUSLY MANAGED BY DECREASING THE PROGRAMMED ATRIAL SENSITIVITY. HOWEVER, THE STORED EPISODES SEEN DURING THE (B)(6) 2021 INTERROGATION ARE REPORTEDLY WORSE THAN ANYTHING SEEN IN THE PAST. PROVOCATIVE TESTING WAS PERFORMED AND NOISE ON THE ATRIAL EGM WAS REPRODUCED ALONG WITH VENTRICULAR OVERSENSING WITH THE PATIENT LYING ON HER BACK WHILE TURNING HER HEAD FROM SIDE TO SIDE. THE EGM NOISE WAS NOT ABLE TO BE REPRODUCED VIA ISOMETRICS, VALSALVA, DEEP RESPIRATION OR COUGHING. THE POST-V AND POST-R REFRACTORY PERIODS WERE SET OUT TO 155MS AND THE V SENSITIVITY VALUE WAS DECREASED TO 0.8MV. FOLLOWING THESE ADJUSTMENTS, FURTHER VENTRICULAR OVERSENSING WAS UNABLE TO BE REPRODUCED AND THE IMPACT ON INAPPROPRIATE MODE SWITCH WILL BE EVALUATED OVER TIME.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11691219 ↗InjurySep 21, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN INFECTION RELATIVE TO ENTIRE IMPLANTED SYSTEM WAS REPORTED. THE ENTIRE SYSTEM WAS REPLACED.
Patient problems: Unspecified Infection
MAUDE report 10563042 ↗MalfunctionSep 3, 2020Over-Sensing; Low impedance; Over-Sensing; Low impedance
SORIN / LIVA NOVA PROVIDED THE FOLLOWING INFORMATION: IN REVIEWING AVAILABLE EPISODES WITHIN THE PROGRAMMER FILES, IT APPEARS THAT NON-PHYSIOLOGIC ATRIAL OVERSENSING IS PRESENT. IN ADDITION, HISTORICAL LEAD IMPEDANCE MEASUREMENTS APPEAR TO INTERMITTENTLY SHOW LOW DAILY VALUES.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10491415 ↗InjuryJun 11, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
LIVANOVA PROVIDED THE FOLLOWING INFORMATION: EXPLANTED DUE TO INFECTION.
Patient problems: Unspecified Infection
MAUDE report 10145923 ↗MalfunctionApr 27, 2020Fracture; Naturally Worn; Fracture; Naturally Worn
IT WAS REPORTED IN REGARD TO THIS RV LEAD THAT: THIS LEAD WAS FRACTURED DUE TO SUBCLAVIAN CRUSH. THE LEAD WAS EXPLANTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10000914 ↗MalfunctionDec 18, 2019Over-Sensing; Ambient Noise Problem; Over-Sensing; Ambient Noise Problem
LIVANOVA/MICROPORT PROVIDED THE FOLLOWING INFORMATION: OVERSENSING AND NOISE WERE REPORTED ON THIS LEAD.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9489023 ↗MalfunctionNov 6, 2019Fracture; Fracture
RIGHT VENTRICULAR LEAD FRACTURE WAS REPORTED BY THE PHYSICIAN. THE SUBJECT LEAD WAS REPLACED AND REMAINS IN-SITU (CAPPED).
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9285775 ↗
Other Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes devices
- Tendril™ STSSt. Jude Medical, Inc. · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes438 deaths19,632 reports
- Tendril™ STSSt. Jude Medical, Inc. · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes200 deaths12,708 reports
- INGEVITY™ MRI 7741Boston Scientific Corporation · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes36 deaths7,874 reports
- INGEVITY™+ 7841Boston Scientific Corporation · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes15 deaths7,419 reports
- Tendril™ STSSt. Jude Medical, Inc. · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes190 deaths6,776 reports
- INGEVITY™+ 7842Boston Scientific Corporation · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes21 deaths5,995 reports
- SelectSecure™ MRI SureScan™ 383069Medtronic, Inc. · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes50 deaths5,027 reports
- CapSureFix Novus MRI™ SureScan® 5076-45Medtronic, Inc. · Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes40 deaths5,000 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page